Latest news with #Focal-One
Hi Dubai
21-04-2025
- Health
- Hi Dubai
UAE Healthcare Breaks Ground with Historic Surgeries and Future-Ready Innovations in 2025
The UAE's healthcare sector is cementing its global leadership in 2025 through a string of landmark procedures and groundbreaking innovations across critical specialties. From historic surgeries to futuristic tech, the nation's medical institutions are redefining excellence. Kings College Hospital London Dubai recently performed the city's first liver transplant on a 13-month-old child, born with biliary atresia and a congenital heart defect. The complex case, supported by Al Jalila Foundation, highlights the depth of pediatric expertise now available locally. Cleveland Clinic Abu Dhabi made global headlines with the world's first remotely performed robotic-assisted focal therapy for prostate cancer. Using the Focal-One system, the procedure eliminated the need for invasive surgery. The hospital also carried out the UAE's first simultaneous robotic kidney transplant for donor and recipient using a single robot. Women's health saw a leap forward at Corniche Hospital with a minimally invasive egg collection and freezing procedure, offering a new frontier in fertility care. In regenerative medicine, the Abu Dhabi Stem Cells Centre reported promising results for Type 1 diabetes treatment using umbilical cord-derived stem cells. Major strides were also revealed at Arab Health 2025, where Emirates Health Services introduced two ambitious projects: artificial heart transplantation and pancreatic cell transplantation. Meanwhile, a clinical trial in Abu Dhabi on StromaForte for knee osteoarthritis showed strong potential in cell-based therapy. Looking ahead, M42 will bring heavy ion therapy—among the most advanced cancer treatments—to Cleveland Clinic Abu Dhabi. The hospital also launched a BioButton-powered remote monitoring programme for cancer patients during Abu Dhabi Global Healthcare Week, underscoring the UAE's commitment to personalized, tech-driven care. With AI, robotics, and precision medicine at the forefront, the UAE continues to reshape the future of global healthcare. News Source: Emirates News Agency
Gulf Today
19-04-2025
- Health
- Gulf Today
UAE healthcare sector sees massive advancement
The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various specialties. The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of care. Kings College Hospital London Dubai announced on Thursday the city's first liver transplant on a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). He was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure. Cleveland Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery. In January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one robot. Corniche Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive medicine. The UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. The Emirates Health Services (EHS) unveiled two innovative projects – an 'Artificial Heart Transplantation' and 'Pancreatic Cell Transplantation' at Arab Health 2025 in January. In April, the Department of Health – Abu Dhabi completed a groundbreaking clinical trial in Abu Dhabi. WAM
Al Etihad
18-04-2025
- Health
- Al Etihad
UAE healthcare sector advances in 2025 with rare surgeries, innovative treatments
18 Apr 2025 14:13 ABU DHABI (WAM)The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of College Hospital London Dubai announced on Thursday the city's first liver transplant on an infant, a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). The child was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) Emirates Health Services (EHS) unveiled two innovative projects – an Artificial Heart Transplantation and an Pancreatic Cell Transplantation at Arab Health 2025 in April, the Department of Health – Abu Dhabi also completed a groundbreaking clinical trial in Abu Dhabi. The treatment, StromaForte, has shown a favourable safety profile and significant therapeutic potential for knee osteoarthritis, marking a significant step in evaluating cell-based therapies for degenerative joint diseases.M42, a leading global health technology company powered by AI, is meanwhile set to build a heavy ion therapy facility at Cleveland Clinic Abu Dhabi, bringing one of the most advanced and effective cancer treatment technologies to the Middle East. During Abu Dhabi Global Healthcare Week 2025, which concluded on Thursday, Cleveland Clinic Abu Dhabi also unveiled initiatives and new technologies to improve cancer patient care, including an innovative remote monitoring programme, using the BioButton wearable device, for cancer patients at the Fatima Bint Mubarak Centre.
Zawya
18-04-2025
- Health
- Zawya
UAE healthcare sector advances with rare surgeries, innovative treatments
ABU DHABI - The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various specialties. The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of care. Kings College Hospital London Dubai announced on Thursday the city's first liver transplant on a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). He was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure. Cleveland Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery. In January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one robot. Corniche Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive medicine. The UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. The Emirates Health Services (EHS) unveiled two innovative projects – an 'Artificial Heart Transplantation' and 'Pancreatic Cell Transplantation' at Arab Health 2025 in January. In April, the Department of Health – Abu Dhabi completed a groundbreaking clinical trial in Abu Dhabi. StromaForte has shown a favourable safety profile and significant therapeutic potential for knee osteoarthritis, marking a significant step in evaluating cell-based therapies for degenerative joint diseases. M42, a leading global health technology company powered by AI, is set to build a heavy ion therapy facility at Cleveland Clinic Abu Dhabi, bringing one of the most advanced and effective cancer treatment technologies to the Middle East. During Abu Dhabi Global Healthcare Week 2025, which concluded on Thursday, Cleveland Clinic Abu Dhabi also unveiled initiatives and new technologies to improve cancer patient care, including an innovative remote monitoring programme using the 'BioButton' wearable device, for cancer patients at the Fatima Bint Mubarak Centre.
Al Bawaba
17-04-2025
- Health
- Al Bawaba
Cleveland Clinic Abu Dhabi collaborates with Cleveland Clinic in the U.S. to perform first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer
Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration with experts from Cleveland Clinic in the U.S., the team performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound innovative surgery enabled real-time collaboration between Dr. Ruben Olivares, Urologist in the Glickman Urological Institute at Cleveland Clinic, supporting remotely from Ohio, and Dr. Waleed A. Hassen, Department Chair of Urology, at Cleveland Clinic Abu Dhabi, who managed the on-site procedural execution. Lasting approximately one hour, the remote procedure was completed successfully without complications, demonstrating the transformative potential of advanced technology in expanding access to specialized procedure, powered by cutting-edge technology and robust communication networks, offers unparalleled access to specialized surgical expertise, even in remote or underserved regions. By combining local and global expertise, it addresses critical gaps in healthcare equity and training while enabling minimally invasive treatment options, such as focal therapy for prostate cancer. However, widespread access to such advanced procedures remains a significant challenge in many parts of the on the milestone, Hasan Jasem Al Nowais, Chairman of Cleveland Clinic Abu Dhabi, said: 'This innovative remote procedure is a remarkable feat that presents the possibility to manage complex care needs across borders and close global health inequities. We were delighted to have partnered with our colleagues in the U.S. to set a new standard for transcontinental healthcare.' H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: "Abu Dhabi is rapidly evolving towards establishing one of the world's most intelligent and efficient healthcare systems. Our progress is powered by advanced infrastructure and innovation-driven regulatory frameworks, which enhance healthcare quality and accessibility. Cleveland Clinic Abu Dhabi's achievements mark another milestone in our journey of healthcare excellence, showcasing the sector's commitment to pioneering medical solutions and cutting-edge technologies. This success strengthens our local and global partnerships, reaffirming the Emirate's dedication to safeguarding the health and well-being of our community and beyond." Highlighting the hospital's leadership in medical innovations, Dr. Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi said: 'Cleveland Clinic Abu Dhabi has always been at the forefront of integrating advanced technology with world-class care. Remote procedures represent the future of healthcare, pushing the boundaries of what can be achieved in medicine. This procedure exemplifies our vision of leveraging cutting-edge technology with collaborative expertise to set new benchmarks in patient care. It is exciting to partner with our colleagues in the US to make history and transform patient outcomes on a global scale. The success of this procedure marks a new era in global surgical collaboration. We envision a future where advanced treatments are accessible to patients regardless of location, reducing health disparities and improving outcomes for everyone.'The journey to this remarkable achievement began in October 2023, when Cleveland Clinic Abu Dhabi introduced the Focal One high-intensity focused ultrasound (HIFU) therapy to patients in Abu Dhabi. Focal One represents a novel approach to treating non-metastatic prostate tumors, utilizing advanced imaging technology to precisely target cancerous cells. This method enables effective tumor treatment while minimizing the risk of side Waleed A. Hassen, Department Chair of Urology at Cleveland Clinic Abu Dhabi, explains: "There are many ways to treat prostate cancer, and one of the options is focal therapy. It's a non-invasive procedure where we use a robotically controlled arm to deliver treatment. Once the treatment plan is in place, the machine delivers it precisely. This is proof of principle that we can contour the prostate, design the plan, and execute it remotely. The procedure typically takes about an hour, with the Focal-one screen visible to both the surgical team and the ultrasound team, ensuring shared expertise. Dr. Ruben Olivares, M.D., Urologist in the Glickman Urological Institute at Cleveland Clinic said: 'We are thrilled to have successfully performed the first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer by working in tandem with our partners at Cleveland Clinic Abu Dhabi. Here at Cleveland Clinic, we use cutting-edge technology, but unfortunately, it's not available in many places throughout the U.S. and in the world. We look forward to expanding the adoption of the latest alternative minimally invasive options and increasing access for patients throughout the world with this first step." This milestone comes as Cleveland Clinic Abu Dhabi celebrates a decade of excellence in care, making remarkable strides in advancing healthcare through integration of technology. As the hospital continues to explore the potential of remote procedures, the implications stretch far beyond prostate cancer treatment. This success not only opens new pathways for surgical education and collaboration but also drives global accessibility to advanced care. © 2000 - 2025 Al Bawaba ( Signal PressWire is the world's largest independent Middle East PR distribution service.
